Kfar-Sava, Israel Clinical Trials

A listing of Kfar-Sava, Israel clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 16 clinical trials
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia

The main purpose of this study is to evaluate the efficacy and safety of M281 in participants with warm autoimmune hemolytic anemia (wAIHA).

Momenta Investigational Site
 (6.6 away) Contact site
  • 15 views
  • 18 Jun, 2021
  • +138 other locations
Study to Evaluate Imetelstat (GRN163L) in Subjects With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

The purpose of this study is to evaluate the efficacy and safety of imetelstat in transfusion dependent participants with low or intermediate-1 risk myelodysplastic syndrome (MDS) that is relapsed/refractory to erythropoiesis-stimulating agent (ESA) treatment.

blood transfusion
Rabin Medical Center, Beilinson Hospital
 (6.6 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +163 other locations
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma

Unity NHL - A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + Umbralisib with or without Bendamustine and Umbralisib alone in Patients with Previously Treated Non-Hodgkin's Lymphoma

btk inhibitor
large b-cell lymphoma
diffuse large b-cell lymphoma
b-cell lymphoma
hodgkin's disease
TG Therapeutics Investigational Trial Site
 (6.6 away) Contact site
  • 0 views
  • 16 Jun, 2021
  • +201 other locations
Nivolumab With Gemcitabine Oxaliplatin + Rituximab in r/r Elderly Lymphoma Patients

This study evaluates the addition of nivolumab to gemcitabine, oxaliplatin plus rituximab in case of B-cell lymphoma

anthracyclines
cell transplantation
rituximab
aggressive non-hodgkin's lymphoma
hodgkin's disease
The Chaim Sheba Medical Center - Division of Hematology and Bone-Marrow Transplantation
 (9.0 away) Contact site
  • 234 views
  • 02 Feb, 2021
  • +124 other locations
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the clinical efficacy (GALAXI 1), clinical and endoscopic efficacy (GALAXI 2 and GALAXI 3) and safety of guselkumab in participants with Crohn's disease.

abdominal pain
ileocolitis
ileitis
endoscopy
fistulising crohn's disease
Rabin Med Ctr Beilinson Hosp
 (3.5 away) Contact site
  • 792 views
  • 18 Jun, 2021
  • +796 other locations
Efficacy & Safety of TD-1473 in Ulcerative Colitis

A Phase 2b/3 set of studies to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473 in subjects with moderately-to-severely active ulcerative colitis with up to 60 weeks of treatment.

corticosteroids
aminosalicylates
immunomodulators
Theravance Biopharma Investigational Site
 (6.6 away) Contact site
  • 75 views
  • 28 Jan, 2021
  • +202 other locations
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

A 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis who have participated in the Maintenance Study of Protocol 0157

remission
Theravance Biopharma Investigational Site
 (6.6 away) Contact site
  • 7 views
  • 28 Jan, 2021
  • +158 other locations
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

The purpose of this Phase 2/3 study is to evaluate efficacy and safety of the combination of selinexor and R-GDP (SR-GDP) in patients with RR DLBCL who are not intended to receive hematopoetic stem cell transplantation (HSCT) or chimeric antigen receptor T cell (CAR-T) therapy. The Phase 2 portion of …

Rabin Medical Center
 (6.6 away) Contact site
  • 37 views
  • 31 May, 2021
  • +70 other locations
A Multicenter Randomized Double-Blind Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Ulcerative Colitis

The objectives of Sub-Study 1 are to evaluate the efficacy, safety, and pharmacokinetics of risankizumab as induction treatment in subjects with moderately to severely active ulcerative colitis (UC), and to identify the appropriate induction dose of risankizumab for further evaluation in Sub-Study 2. The objective of Sub-Study 2 is to …

remission
Rabin Medical Center /ID# 167403
 (6.6 away) Contact site
  • 604 views
  • 16 Jun, 2021
  • +772 other locations
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis

This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability of belapectin compared with placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis and clinical signs of portal hypertension but without esophageal varices at baseline.

carcinoma
dyslipidemia
diabetes
nonalcoholic steatohepatitis
vasectomy
Rabin Medical Center - Beilinson Hospital
 (6.6 away) Contact site
  • 0 views
  • 02 Jun, 2021
  • +90 other locations